Terms: = Leukemia AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Prognosis
80 results:
1. Intracranial residual lesions following early intensification in a patient with T-cell acute lymphoblastic leukemia: a case report.
Nagamatsu Y; Isoda T; Inaji M; Oyama J; Niizato D; Tomomasa D; Mitsuiki N; Yamashita M; Kamiya T; Imai K; Kanegane H; Morio T; Takagi M
BMC Pediatr; 2024 May; 24(1):304. PubMed ID: 38704558
[TBL] [Abstract] [Full Text] [Related]
2. meta-analysis of decitabine pretreatment-based allogeneic hematopoietic stem cell transplantation affecting transplantation-related complications and prognosis in patients with malignant hematological disease.
Li L; Zhao Z; Li X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):69-75. PubMed ID: 38279480
[TBL] [Abstract] [Full Text] [Related]
3. The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms.
d'Izarny-Gargas T; Isnard P; Boudhabhay I; Buob D; Moktefi A; Linster C; Hummel A; Esteve E; Audard V; Lazareth H; Maroun N; Hertig A; Gosset C; Jouzel C; Permal S; Domenger C; Kosmider O; Rabant M; Karras A; Duong Van Huyen JP
Kidney Int; 2023 Dec; 104(6):1206-1218. PubMed ID: 37769965
[TBL] [Abstract] [Full Text] [Related]
4. Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome.
Nagehan P; Sabbir M; Song J; Mohammad H
J Clin Exp Hematop; 2023; 63(3):173-176. PubMed ID: 37766563
[TBL] [Abstract] [Full Text] [Related]
5. Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients.
Fontana D; Crespiatico I; Crippa V; Malighetti F; Villa M; Angaroni F; De Sano L; Aroldi A; Antoniotti M; Caravagna G; Piazza R; Graudenzi A; Mologni L; Ramazzotti D
Nat Commun; 2023 Sep; 14(1):5982. PubMed ID: 37749078
[TBL] [Abstract] [Full Text] [Related]
6. Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.
Mark C; Meshinchi S; Joyce B; Gibson B; Harrison C; Bergmann AK; Goemans BF; Pronk CJH; Lapillonne H; Leverger G; Antoniou E; Schneider M; Attarbaschi A; Dworzak M; Stary J; Tomizawa D; Ebert S; Lejman M; Kolb EA; Schmiegelow K; Hasle H; Abla O
Br J Haematol; 2024 Feb; 204(2):576-584. PubMed ID: 37743097
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Research in Chronic Lymphocytic leukemia in Pakistan; A Systematic Review.
Ammad Ud Din M; Shahzad M; Ashraf A; Liaqat H; Jaan A; Anwer F
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629773
[No Abstract] [Full Text] [Related]
8. Homoharringtonine-Based Induction Therapy Reduces the Recurrence Rate of Pediatric Acute Myeloid leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Wang B; Wen X; Zhang R; Zhu G; Wu Y; Zhang Y; Lin W; Yu J; Fan J; Li J; Yang J; Qin M; Zheng H
Cell Transplant; 2023; 32():9636897231183559. PubMed ID: 37470325
[TBL] [Abstract] [Full Text] [Related]
9. A Coumarin-Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins.
Nirgude S; Shahana M V ; Ravindran F; Kumar S; Sharma S; Mahadeva R; Mhatre A; Karki SS; Choudhary B
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446888
[TBL] [Abstract] [Full Text] [Related]
10. [Clinical Application Examples of a Next-Generation Sequencing based Multi-Genepanel Analysis].
Enko D; Schaflinger E; Müller DJ
Dtsch Med Wochenschr; 2023 Jun; 148(11):695-702. PubMed ID: 37216946
[TBL] [Abstract] [Full Text] [Related]
11. Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.
Wang ML; Jurczak W; Zinzani PL; Eyre TA; Cheah CY; Ujjani CS; Koh Y; Izutsu K; Gerson JN; Flinn I; Tessoulin B; Alencar AJ; Ma S; Lewis D; Lech-Maranda E; Rhodes J; Patel K; Maddocks K; Lamanna N; Wang Y; Tam CS; Munir T; Nagai H; Hernandez-Ilizaliturri F; Kumar A; Fenske TS; Seymour JF; Zelenetz AD; Nair B; Tsai DE; Balbas M; Walgren RA; Abada P; Wang C; Zhao J; Mato AR; Shah NN
J Clin Oncol; 2023 Aug; 41(24):3988-3997. PubMed ID: 37192437
[TBL] [Abstract] [Full Text] [Related]
12. Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells.
Tsubaki M; Takeda T; Matsuda T; Kimura A; Tanaka R; Nagayoshi S; Hoshida T; Tanabe K; Nishida S
BMB Rep; 2023 Feb; 56(2):78-83. PubMed ID: 36195570
[TBL] [Abstract] [Full Text] [Related]
13. An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma.
Izutsu K; Makita S; Nosaka K; Yoshimitsu M; Utsunomiya A; Kusumoto S; Morishima S; Tsukasaki K; Kawamata T; Ono T; Rai S; Katsuya H; Ishikawa J; Yamada H; Kato K; Tachibana M; Kakurai Y; Adachi N; Tobinai K; Yonekura K; Ishitsuka K
Blood; 2023 Mar; 141(10):1159-1168. PubMed ID: 36150143
[TBL] [Abstract] [Full Text] [Related]
14. [Predictive Value of Acute Phase Proteins on the prognosis of Patients with Acute Myeloid leukemia].
Wu XJ; Wang YQ; Yang XY; Lin XS; Qiu MH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1086-1093. PubMed ID: 35981366
[TBL] [Abstract] [Full Text] [Related]
15. Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes.
Volpe VO; Al Ali N; Chan O; Padron E; Sallman DA; Kuykendall A; Sweet K; Lancet JE; Komrokji RS
Br J Haematol; 2022 Aug; 198(4):713-720. PubMed ID: 35751140
[TBL] [Abstract] [Full Text] [Related]
16. [Intensive chemotherapy with tyrosine kinase inhibitors in philadelphia-positive acute lymphoblastic leukemia].
Benavente R; Cid F; Puga B; Molina J; Bass F; Andrade A; Monardes V; Encina A; Cabrera ME
Rev Med Chil; 2021 Sep; 149(9):1249-1257. PubMed ID: 35319677
[TBL] [Abstract] [Full Text] [Related]
17. Systemic mastocytosis with myeloid sarcoma and B-CLL: molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature.
Decruyenaere P; Mazure D; Moors I; Van Dorpe J; Van der Linden M; Denys B; Hofmans M; Offner F
Acta Clin Belg; 2023 Feb; 78(1):58-66. PubMed ID: 35098906
[TBL] [Abstract] [Full Text] [Related]
18. [Comparison of four prognostic scoring system in patients with early asymptomatic chronic lymphocytic leukemia patients].
Sha YQ; Shen H; Wu W; Xia Y; Miao Y; Cao L; Wang L; Fan L; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):834-839. PubMed ID: 34788923
[No Abstract] [Full Text] [Related]
19. Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group.
Elgarten CW; Wood AC; Li Y; Alonzo TA; Brodersen LE; Gerbing RB; Getz KD; Huang YV; Loken M; Meshinchi S; Pollard JA; Sung L; Woods WG; Kolb EA; Gamis AS; Aplenc R
Pediatr Blood Cancer; 2021 Dec; 68(12):e29281. PubMed ID: 34596937
[TBL] [Abstract] [Full Text] [Related]
20. Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia: a systematic review of the literature.
Lai M; Pampena R; Cornacchia L; Odorici G; Piccerillo A; Pellacani G; Peris K; Longo C
Int J Dermatol; 2022 May; 61(5):548-557. PubMed ID: 34351635
[TBL] [Abstract] [Full Text] [Related]
[Next]
